Catheter ablation using a new imaging system for atrial fibrillation
Part of Heart & circulation clinical trials.
This study tests a new navigation and imaging system called VERAFEYE that helps doctors perform catheter ablation (a procedure to fix irregular heartbeats) more precisely. It may help people with paroxysmal atrial fibrillation get a safer and more effective treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a type of irregular heartbeat called paroxysmal atrial fibrillation (it comes and goes).
- Your doctor must have decided that you are a candidate for a catheter ablation procedure.
- You must be able to understand the study and give written consent.
- You must be willing to complete all study-related visits and tests at an approved study center.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging system that helps doctors see inside the heart during a procedure to treat atrial fibrillation (an irregular heartbeat). It may allow for more precise treatment and improve outcomes for people with this condition.
This trial tests a new way to deliver energy (FARAPULSE PFA system) to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to see if these new waveforms can safely and effectively stop AF symptoms and improve quality of life.
This trial tests whether a “virtual” computer map created from your heart scans can help doctors do catheter ablation to treat atrial fibrillation (AF). It aims to improve the procedure for people whose AF symptoms were not controlled well with anti-arrhythmia medicines.
This study tests a new imaging system (VERAFEYE) that helps doctors guide catheter ablation, a procedure to fix irregular heartbeats like atrial fibrillation. It aims to see if the system makes the procedure safer or more effective.
This study tests a new imaging catheter (VERAFEYE) to help doctors guide ablation procedures for atrial flutter or atrial fibrillation. It may lead to safer, more precise treatment of these heart rhythm problems.
This study is a registry that tracks the real-world use of a new imaging system called VERAFEYE during heart procedures for atrial fibrillation (irregular heartbeat) or left atrial appendage closure (stroke prevention). By participating, you help doctors learn how well this imaging tool works in everyday practice, and it may help guide your procedure more precisely.
Hear when a new Paroxysmal Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.